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Introduction: Glutathione (GSH), a major redox regulator and antioxidant, is decreased in cerebrospinal fluid and prefrontal 
cortex of schizophrenia patients [1]. Genes of the key GSH-synthesizing enzyme, glutamate-cysteine ligase catalytic (GCLC) and 
modifier (GCLM) subunit, are associated with schizophrenia suggesting a genetic origin for impaired GSH synthesis [2]. This redox 
deregulation together with environmental oxidative stress may play a major role in schizophrenia. Using GCLM knock-out (KO) mice 
with 70% decreased brain GSH levels, we have shown that redox deregulation results in abnormal brain morphology and function and 
behavioral abnormalities [3]. As schizophrenia is likely a developmental disease, we investigated the impact of genetically deregulated 
redox system on the neurochemical profile of the developing cortex in GCLM KO mice. In addition, we now tested whether partially 
restoring the redox balance with the GSH precursor and antioxidant N-acetylcysteine (NAC) could normalize the neurochemical 
profile of GCLM KO mice. 
Methods: Wild-type (WT) and GCLM KO mice 
received NAC (Fluimucil, Zambon, Switzerland) in 
drinking water at 2.4 g/L before and during mouse 
pregnancy and after birth throughout the entire 
experimental period. The neurochemical profile in the 
frontal cortex of KO and WT mice receiving either 
NAC treatment or only tap water (non-treated mice) 
was determined on postnatal days 10, 20, 30, 60 and 
90 as previously described [4,5]. Briefly, 1H NMR 
spectroscopy was performed on a 14.1 T, 26 cm 
VNMRS spectrometer (Varian, Magnex) using a 
home-built 8 mm diameter quadrature surface coil. 
Mice were anaesthetized under 1 to 2% isoflurane in 
oxygen gas. Field homogeneity was adjusted by 
FASTMAP [6], and 1H NMR spectra were acquired 
from VOIs of 2.5 to 4 μL placed in the anterior cortex, using SPECIAL [5,7] with TE of 2.8 ms and TR of 4 s. Typically, spectra were 
acquired with 480 scans. Metabolite concentrations were estimated with LCModel [8], using corrections for water content variation 
during development. Data was analyzed with a combined statistical linear model accounting for several variables including genotype, 
age and NAC treatment. 
Results and discussion: As previously shown [4], GCLM KO mice displayed nearly undetectable GSH levels compared to WT. 
This GSH depletion triggered alterations of its metabolic precursor glutamate at P20 (+12%, P<0.05). Cortical glutamine, produced 
from glutamate, was also increased in KO animals (+35%, P<0.001). At this age, when compared to WT, KO mice also showed higher 
cortical myo-inositol (+24%, P<0.05) and N-acetylaspartate (NAA) (+14%, P<0.01) concentrations. Furthermore, the ratio 
glutamine/glutamate was increased at all measured ages (P<0.05 at P20/P30). Finally, adult KO mice (P90) displayed increased 
cortical levels of lactate (+68%, P<0.001) and alanine (+28%, P<0.05). Chronic supplementation with NAC did not affect cortical 
GSH levels. It was expected that NAC acting as GSH precursor could not restore GSH levels in KO animals since a surplus of 
precursor availability cannot overcome KO-induced enzyme dysfunction. However, via its direct antioxidant properties NAC was 
expected to boost the antioxidant system in KO animals.  The neurochemical profile in the cortex of NAC-supplemented WT and KO 
animals was clearly distinct from non-NAC-treated mice and the concentrations of numerous metabolites notably modified at P10. 
Interestingly, concentrations of glutamate, glutamine, myo-inositol and N-acetylaspartate at P20 in the cortex of NAC-treated KO 
animals were normalized to the levels of non-treated controls (P>0.05 for all).  
Compared to WT mice, GCML KO mice displayed altered concentrations of glutamate, glutamine and their ratio in the anterior 
cortex, suggesting impaired glutamatergic neurotransmission. Alterations in glutamatergic metabolism are frequently found in brains 
of schizophrenia patients, and the increased Glutamine/Glutamate ratio in particular translates well to patient studies [9].  Late 
accumulation of lactate and alanine at P90 points towards modified mitochondrial metabolism. NAA accumulation may reflect 
reduced deacetylation by oligodendrocytes, raising the possibility of impaired myelination processes in the anterior cortex of GCLM 
KO mice, which needs further investigation. The results highlight P20 as sensitive period during development for these alterations. 
Although not able to restore GSH levels, chronic NAC supplementation had protective qualities during this critical period and restored 
most metabolic alterations in the cortex of KO mice. This suggests that NAC can partially counteract the dysregulated redox status. 
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Table 1. Sumary of metabolic alterations in the cortex of GCLM HZ and KO mice
relative to WT and effect of NAC. Arrows indicate increase or reduction of metabolite
concentration (↓/↑ P<0.05, ↓↓/↑↑ P<0.01). Orange squares indicate normalization by
NAC treatment.  
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